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Retrospective Impact of COVID-19 Pandemic on Hypertension Management in
Primary Care
Carly Barnes, PharmD; Jayme Johnston, PharmD, BCACP; Judy Wong, PharmD, BCACP
Background

Preliminary Results

Discussion

• COVID-19 has imposed many challenges to clinical practices
across the country, especially within the healthcare system1
and ambulatory care is no exception
• The pandemic introduced novel barriers to care for
hypertension management including the need to switch from
office-based care to virtual visits
• Clinical pharmacists at our institution already incorporated
virtual and telephonic visits prior to pandemic

Patient Demographics

• Preliminary statistical analysis shows that the change in
patients at goal blood pressure managed by clinical
pharmacists is not statistically significant when compared to
usual care
• There was no change in patients at goal with change to novel
barrier of virtual visits
• The COVID-19 pandemic may have affected the degree of
care that patients received. A potential explanation for the
decrease in metric could be related to surges and patient
comfort level with seeking care for chronic disease
management, such as hypertension
• There was a higher rate of no shows and appointment
cancellations to PharmD appointments likely related to more
frequently scheduled follow-up appointments
• One of the two clinics included in the study had a higher
number of virtual visits potentially because the clinic is in a
more rural area
• Full statistical analysis to be completed by May 2022

Study Purpose
• The purpose of this study is to examine hypertension
management at our institution during the pandemic to
determine whether clinical pharmacist care was more
resilient to these disruptive effects compared to usual care by
the primary care team

Objectives
•Primary Objective:
• Evaluate the percent change in patients at goal blood
pressure managed by clinical pharmacists compared to
usual care
•Secondary Objectives:
• Percent of virtual and in office visits
• Percent of patients who canceled or ‘no showed’ to
appointments

Methods
•Study Design
• Retrospective chart review quality improvement
•Inclusion Criteria
• Patients aged 18 to 85 years
• Active diagnosis of hypertension
• Established care with primary care provider at the clinics
included in the study
• Patients with ambulatory visits and/or virtual visits within
either September 2020 and/or March 2021
•Exclusion Criteria
• Hospice/end of life care
• History of kidney transplant
• End stage renal disease (ESRD) on dialysis
• Pregnant women
• Hypertension managed by specialists outside of the
primary care setting or in other health systems

Average Age

Percent Male

68
63
66
69

55%
36%
60%
58%

PharmD 2020
PharmD 2021
Usual Care 2020
Usual Care 2021

History of
Cardiovascular
Disease
60%
82%
50%
45%

History of
Diabetes
95%
86%
35%
32%

Percent Antihypertensive Use
60%
50%
40%
30%
20%
10%
0%

ACEi
PharmD 2020

CCB
ARB
PharmD 2021

Thiazide
Usual Care 2020

BB
Other
Usual Care 2021

Primary Objective
Patients at Metric BP goal of < 140/90
100%

85%

80%

73%

60%

67%

Z-score = 0.59
77%

40%
20%
0%
PharmD 2020

# of patients at Metric BP goal of <140/90
PharmD 2021
Usual Care 2020
Usual Care 2021

Secondary Objectives
No show or Appointment
Cancellation

Virtual

In-Office

PharmD 2020

90%

PharmD 2020

90%

10%

PharmD 2021

68%

PharmD 2021

77%

23%

Usual Care
2020

52%

Usual Care 2020

30%

70%

Usual Care
2021

47%

Usual Care 2021

12%

88%

Limitations
• Small sample size
• Did not evaluate the same patient population from
September 2020 and March 2021
• One clinic had a blood pressure workflow implemented
during the pandemic
• Blood pressures may not have been updated as frequently as
they were pre-pandemic
• Did not account for pandemic ‘surges’ and impact on
workflow

Future Considerations
• Evaluate effectiveness of new workflows implemented for
hypertension management on metrics
• Compare blood pressure control of patients who were
managed by specialists compared to clinical pharmacists
• Evaluate if there were significant changes in practice
regarding prescribing during the pandemic
• Evaluate the impact of no show or appointment cancellations
on achievement of hypertension metric
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